-
The Future of Hematology: Expert Insights from EHA Conference
Discover the latest advancements in hematology with our video series covering the European Hematology Association conference. This series offers a comprehensive analysis of pivotal studies such as the A031501/AMBASSADOR trial,…
-
ESMO China Voice | Professor Bin Shao : Comprehensive Genomic Analysis of Advanced HR+/HER2- Breast Cancer Patients Using Liquid Biopsy
HR+/HER2- is the most common subtype of breast cancer, accounting for approximately 65% to 70% of all breast cancer cases. Improving the survival benefits for patients with advanced HR+/HER2- breast cancer has always been a hot topic in this field and a unanimous goal for scholars and experts. Exploring the genomic characteristics of advanced HR+/HER2-…
-
Prof. Jun Ma Highlights ASH Conference, Showcasing Chinese Influence on Global Stage
Local time on December 9th, the eagerly awaited 65th American Society of Hematology (ASH) Annual Meeting officially kicked off in San Diego, USA. The Oncology Insight reporting team delved into the forefront, witnessing the impressive presence of “The Voice of China” on the international stage. ASH is one of the largest and most comprehensive international…
-
ASH 2023 | Prof. Fengkui Zhang and Prof. Bing Han Team: KP104 Effectively Controls Intravascular and Extravascular Hemolysis in PNH Patients Without Complement Inhibitor Treatment
Paroxysmal Nocturnal Hemoglobinuria (PNH) is a rare and life-threatening blood disorder. Due to the complexity of complement biology and various pathogenic pathways, there remains a significant unmet clinical need, urgently requiring next-generation drugs with superior efficacy and dosing convenience compared to current therapies. At the recently held 65th American Society of Hematology (ASH) Annual Meeting,…
-
ASH 2023 | West China Team: Exploration of Blinatumomab and Reduced Dosing of Cyclophosphamide before and after Allogeneic Hematopoietic Stem Cell Transplantation
The 65th American Society of Hematology (ASH) Annual Meeting was held in San Diego, California, from December 9 to 12, 2023. ASH Annual Meeting is the largest and most comprehensive international event covering both basic and clinical research in hematlogy. This year, the Hematology Department at West China Hospital, Sichuan University, presented two oral reports,…
-
ASCO-GU Interview | Dr. Antonio Cigliola: Utility of FDG-PET to predict a pelvic lymph node involvement (LNI) in patients (pts) with MIBC enrolled in neoadjuvant therapy trials.
Editor’s note: Recently, ASCO-GU, the top event in the field of genitourinary cancers, was held in San Francisco, USA. During the meeting, Dr. Antonio Cigliola shared a study on using…
-
Universal Anti-CD7 CAR-T Cells Targeting T-ALL: Functional Analysis and Potential Applications
Chimeric antigen receptor T cell (CAR-T) therapy has revolutionized the treatment of hematological malignancies. One of the challenges in CAR-T cell therapy is the limited availability of target antigens that…
Connecting Medical Expertise through Media
